Overview
Originally approved by the FDA in 1959 , carisoprodol is a centrally acting muscle relaxant used in painful musculoskeletal conditions in conjunction with physical therapy and other medications . This drug is available by itself in an oral tablet or combined with aspirin, or in a fixed-dose combination with both aspirin and codeine . In January 2012, this drug was classified as a Schedule IV substance under the controlled substances act in several US states due to alarming rates of abuse despite having a low potential for abuse in addition to a low risk of dependence .
Indication
⑴主要用于治疗急性肌肉痉挛及扭伤、急性骨骼肌疼痛等。仅可短期应用，最多2～3周。 ⑵可用于抗焦虑、肌肉松弛、镇静、失眠等。不推荐长期使用。
Associated Conditions
- Acute Pain
- Acute Discomfort
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2021/02/21 | Phase 1 | Terminated | Stratatech, a Mallinckrodt Company | ||
2008/05/05 | Phase 3 | Completed | |||
2008/05/05 | Phase 3 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Proficient Rx LP | 71205-241 | ORAL | 350 mg in 1 1 | 3/1/2019 | |
| NuCare Pharmaceuticals,Inc. | 68071-4610 | ORAL | 350 mg in 1 1 | 2/22/2021 | |
| A-S Medication Solutions | 50090-0281 | ORAL | 350 mg in 1 1 | 2/13/2017 | |
| Contract Pharmacy Services-PA | 67046-911 | ORAL | 350 mg in 1 1 | 9/21/2017 | |
| Golden State Medical Supply, Inc. | 60429-508 | ORAL | 350 mg in 1 1 | 1/16/2023 | |
| Rebel Distributors Corp. | 21695-021 | ORAL | 350 mg in 1 1 | 12/1/2009 | |
| Direct_Rx | 72189-386 | ORAL | 350 mg in 1 1 | 11/9/2022 | |
| PD-Rx Pharmaceuticals, Inc. | 72789-477 | ORAL | 350 mg in 1 1 | 9/16/2025 | |
| H.J. Harkins Company, Inc. | 52959-026 | ORAL | 350 mg in 1 1 | 9/18/2012 | |
| Mylan Pharmaceuticals Inc. | 51525-5901 | ORAL | 250 mg in 1 1 | 6/15/2023 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.